200
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Study on serum Tau protein level and neurodevelopmental outcome of placental abruption with neonatal hypoxic-ischemic encephalopathy

, , , , &
Pages 3887-3893 | Received 30 Aug 2018, Accepted 26 Feb 2019, Published online: 28 Mar 2019

References

  • HullJ, DoddKL. Falling incidence of hypoxic-ischaemic encephalopathy interm infants. BJOG. 1992;99:386–391.
  • WuYW, BackstrandKH, ZhaoS, et al. Declining diagnosis of birth asphyxia in California: 1991–2000. Pediatrics. 2004;114:1584–1590.
  • HayakawaM, ItoY, SaitoS, et al. Executive committee. Incidence and prediction of outcome in hypoxic-ischemic encephalopathy in Japan. Symposium on Japan Society of perinatal and Neonatal Medicine. Pediatr Int. 2014;56:215–221.
  • Douglas-EscobarM, WeissMD. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 2015;169:397–403.
  • BooNY, CheahIG. The burden of hypoxic-ischaemic encephalopathy in Malaysian neonatal intensive care units. SMEDJ. 2016;57:456–463.
  • NelsonKB, EllenbergJH. Obstetric complications as risk factors for cerebral palsy or seizure disorders. JAMA. 1984;251:1843–1848.
  • VannucciRC, PerlmanJM. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics. 1997;100:1004–1014.
  • BuonocoreG, PerroneS, LonginiM, et al. Non protein bound iron as early predictive marker of neonatal brain damage. Brain. 2003;126:1224–1230.
  • MillerSP, RamaswamyV, MichelsonD, et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr. 2005;146:453–460.
  • Gieron-KorthalsM, ColónJH. Hypoxic-ischemic encephalopathy in infant: new challenges. Fetal Pediatr Pathol. 2005;24:105–120.
  • NikasI, DermentzoglouV, TheofanopoulouM, et al. Parasagittal lesions and ulegyria in hypoxic-ischemic encephalopathy: neuroimaging findings and review of the pathogenesis. J Child Neurol. 2008;23:51–58.
  • LaiMC, YangSN. Perinatal hypoxic-ischemic encephalopathy. J Biomed Biotechnol. 2011;2011:1.
  • LiY, ShuzhenY, XueJ. Meta analysis of risk factors of neonatal hypoxic ischemic encephalopathy. Shandong Yiyao. 2013;53:70–71.
  • SunJ, QuS, ZhangC, et al. Neonatal mortality rate and risk factors in northeast China: analysis of 5,277 neonates in 2005. Clin Exp Obstet Gynecol. 2014;41:512–516.
  • Martinez-BiargeM, Diez-SebastianJ, WusthoffCJ, et al. Antepartum and intrapartum factors preceding neonatal hypoxic-ischemic encephalopathy. Pediatrics2013;132:e952–e959.
  • HayesBC, McGarveyC, MulvanyS, et al. A case-control study of hypoxic-ischemic encephalopathy in newborn infants at >36 weeks gestation. Am J Obstet Gynecol. 2013;209:29.e1–29.e19.
  • ChenH, QingxuanL. Investigation on the related risk factors of neonatal hypoxic ischemic encephalopathy. Zhongguo Fuyou Baojian Zazhi. 2014;29:1905–1907.
  • KezhenB, HuangY, XiaozeH, et al. Risk factors and prognosis analysis of neonatal hypoxic- ischemic encephalopathy. Zhongguo Fuyou Baojian Zazhi2016;31:971–973.
  • NasiellJ, PapadogiannakisN, LöfE, et al. Hypoxic ischemic encephalopathy in newborns linked to placental and umbilical cord abnormalities. J Matern Fetal Neonatal Med. 2016;29:721–726.
  • BadawiN, KurinczukJJ, KeoghJM, et al. Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ. 1998;317:1554–1558.
  • ShawGJ, JauchEC, ZemlanFP. Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann Emerg Med. 2002;39:254–257.
  • LvH, WangQ, WuS, et al. Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. Clin Chim Acta. 2015;450:282–297.
  • TakahashiK, HasegawaS, MaebaS, et al. Serum Tau protein level serves as a predictive factor for neurological prognosis in neonatal asphyxia. Brain Dev. 2014;36:670–675.
  • ToorellH, ZetterbergH, BlennowK, et al. Increase of neuronal injury markers Tau and neurofilament light proteins in umbilical blood after intrapartum asphyxia. J Matern Fetal Neonatal Med. 2018;31:2468–2472.
  • SarnatHB, SarnatMS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696–705.
  • Group of Neonatology, Chinese Pediatric Society, Chinese Medical Association. Diagnostic criteria for neonatal hypoxic-ischemic encephalopathy. Zhonghua Er Ke Za Zhi. 2005;43(8):584.
  • LinCJ, LiJP, ZhangXL. Handbook of Infant Development. Beijing: Beijing Child Health Care Institute; 1986.
  • RoeKV. Correlations between Gesell scores in infancy and performance on verbal and non-verbal tests in early childhood. Percept Mot Skills. 1977;45:1131–1134.
  • LiJ, BoT, ChenTQ, et al. Neurobehavioral development in preterm infants: a retrospective study of 181 cases. Zhong Guo Dang Dai Er Ke Za Zhi. 2014;16:696–700.
  • LeeVM, GoedertM, TrojanowskiJQ. Neurodegenerative tauopathies. Annu Rev Neurosci. 2001;24:1121–1159.
  • TrojanowskiJQ, SchuckT, SchmidtML, et al. Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytochem. 1989;37:209–215.
  • TashiroK, HasegawaM, IharaY, et al. Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex. NeuroReport. 1997;8:2797–2801.
  • KleinC, KramerEM, CardineAM, et al. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J Neurosci. 2002;22:698–707.
  • HampelH, BlennowK, ShawLM, et al. Total and phosphorylated tau protein as biological markers of Alzheimer’s disease. Exp Gerontol. 2010;45:30–40.
  • AraiH, TerajimaM, MiuraM, et al. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer’s disease. Ann Neurol. 1995;38:649–652.
  • BlennowK, WallinA, AgrenH, et al. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?Mol Chem Neuropathol. 1995;26:231–245.
  • MorrisM, MaedaS, VosselK, et al. The many faces of tau. Neuron. 2011;70:410–426.
  • LiliangPC, LiangCL, LuK, et al. Relationship between injury severity and serum Tau protein levels in traumatic brain injured rats. Resuscitation. 2010;81:1205–1208.
  • BitschA, HornC, KemmlingY, et al. Serum Tau protein level as a marker of axonal damage in acute ischemic stroke. Eur Neurol. 2002;47:45–51.
  • BielewiczJ, KurzepaJ, Czekajska-ChehabE, et al. Does serum Tau protein predict the outcome of patients with ischemic stroke?J Mol Neurosci. 2011;43:241–245.
  • HuHT, XiaoF, YanYQ, et al. The prognostic value of serum tau in patients with intracerebral hemorrhage. Clin Biochem. 2012;45:1320–1324.
  • OstM, NylénK, CsajbokL, et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology. 2006;67:1600–1604.
  • OkumusN, TurkyilmazC, OnalEE, et al. B. Tau and S100B proteins as biochemical markers of bilirubin-induced neurotoxicity in term neonates. Pediatr Neurol. 2008;39:245–252.
  • HabekD, HodekB, HermanR, et al. Fetal hypoxia–etiology and pathophysiology of hypoxic damage. Lijec Vjesn. 2000;122:82–89.
  • HorváthB, GrassellyM, TurayA, et al. Histologic chorioamnionitis is associated with cerebral palsy. Orv Hetil. 2006;147:211–216.
  • WilcoxAL, CaliseDV, ChapmanSE, et al. Hypoxic/ischemic encephalopathy associated with placental insufficiency in a cloned foal. Vet Pathol. 2009;46:75–79.
  • MirIN, Johnson-WelchSF, NelsonDB, et al. Placental pathology is associated with severity of neonatal encephalopathy and adverse developmental outcomes following hypothermia. Am J Obstet Gynecol. 2015;213:849.e1–849.e7.
  • DerrickM, EnglofI, DrobyshevskyA, et al. Intrauterine fetal demise can be remote from the inciting insult in an animal model of hypoxia-ischemia. Pediatr Res. 2012;72:154–160.
  • ClarkeP, MuniramanH, GardnerD, et al. Investigation of neonatal encephalopathy: the oft-lost placental “black box”. Pediatr Dev Pathol. 2015;18:343–344.
  • WintermarkP, BoydT, GregasMC, et al. Placental pathology in asphyxiated newborns meeting the criteria for therapeutic hypothermia. Am J Obstet Gynecol. 2010;203:579.e1–579.e9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.